Literature DB >> 29161805

Robot assisted radical cystectomy with totally intracorporeal urinary diversion: initial, single-surgeon's experience after a modified modular training.

Angelo Porreca1, Francesco Chessa2, Daniele Romagnoli3, Antonio Salvaggio1, Angelo Cafarelli1, Marco Borghesi3, Lorenzo Bianchi3, Matteo Dandrea1, Daniele D'Agostino1, Donato Dente1, Emanuele Cappa1, Peter Wiklund4, Eugenio Brunocilla3, Riccardo Schiavina3.   

Abstract

BACKGROUND: To report the perioperative and early functional outcomes of patients undergoing Robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion performed by a single surgeon after a modified modular training.
METHODS: The surgeon (A.P.) attained a 30-days modified modular training at a referring Center mentored by a worldwide-recognized robotic surgeon (P.W.). The training program consisted of: 1) e-learning based on 10 hours of theoretical lessons made by the mentor; 2) video-session concerning the different steps of the procedure, 3) step-by-step in vivo modular training. Demographics, intraoperative data and post-operative complications were recorded for each patient.
RESULTS: Twenty-four consecutive patients were prospectively evaluated. Median age was 68.5 years (IQR 59-75). Thirteen (54.2%) and 11 (45.8%) patients received RARC with orthotopic neobladder (ONB) and ileal conduit (IC), respectively. Overall mean (±SD) operative time was 392 (± 34.8) minutes. The median number of lymph node retrieved was 30 (IQR 24-42), the mean intraoperative estimated blood loss (EBL) was 403 mL (±60) with average hospitalization of 7.8 days (±2.2). All procedures were completed successfully without open conversion. A statistically significant difference in terms of overall operative time (OT) and urinary diversion operative time (UDOT) was found in favor of IC group compared to ONB group (P=0.002). Overall complication rate was 33%, 7 out of 9 (88%) were graded as minor (Clavien 1-2). Two (22%) major complications (Clavien 3-5) occurred solely on ONB group.
CONCLUSIONS: Robot-assisted radical cystectomy with totally intracorporeal urinary diversion is a challenging procedure with a steep learning curve. An adequate modular training with an experienced mentor and a skilled robotic team could be essential to reach these optimal results. Further studies investigating the impact of modular learning curve and a dedicated menthorship on operative and functional outcomes after RARC are needed.

Entities:  

Mesh:

Year:  2017        PMID: 29161805     DOI: 10.23736/S0393-2249.17.02970-8

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  7 in total

Review 1.  Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review.

Authors:  Karthik Tanneru; Seyed Behzad Jazayeri; Jatinder Kumar; Muhammad Umar Alam; Daniel Norez; Sabine Nguyen; Soroush Bazargani; Hariharan Palayapalayam Ganapathi; Mark Bandyk; Robert Marino; Shahriar Koochekpour; Shiva Gautam; K C Balaji; Joseph Costa
Journal:  J Robot Surg       Date:  2020-11-22

2.  Is robotic approach useful to palliate advanced bladder cancer? A monocentric single surgeon experience.

Authors:  Federico Mineo Bianchi; Daniele Romagnoli; Daniele D'Agostino; Paolo Corsi; Marco Giampaoli; Antonio Salvaggio; Riccardo Schiavina; Eugenio Brunocilla; Walter Artibani; Angelo Porreca
Journal:  Cent European J Urol       Date:  2019-04-24

Review 3.  Totally intracorporeal robot-assisted urinary diversion for bladder cancer (part 2). Review and detailed characterization of the existing intracorporeal orthotopic ileal neobladder.

Authors:  Hugo Otaola-Arca; Kulthe Ramesh Seetharam Bhat; Vipul R Patel; Marcio Covas Moschovas; Marcelo Orvieto
Journal:  Asian J Urol       Date:  2020-06-08

Review 4.  Totally intracorporeal robot-assisted urinary diversion for bladder cancer (Part 1). Review and detailed characterization of ileal conduit and modified Indiana pouch.

Authors:  Hugo Otaola-Arca; Rafael Coelho; Vipul R Patel; Marcelo Orvieto
Journal:  Asian J Urol       Date:  2020-10-22

5.  Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer.

Authors:  Angelo Porreca; Katie Palmer; Walter Artibani; Alessandro Antonelli; Lorenzo Bianchi; Eugenio Brunocilla; Aldo Massimo Bocciardi; Maurizio Brausi; Gian Maria Busetto; Marco Carini; Giuseppe Carrieri; Antonio Celia; Luca Cindolo; Giovanni Cochetti; Renzo Colombo; Ettore De Berardinis; Ottavio De Cobelli; Fabrizio Di Maida; Amelio Ercolino; Franco Gaboardi; Antonio Galfano; Andrea Gallina; Michele Gallucci; Carlo Introini; Ettore Mearini; Andrea Minervini; Francesco Montorsi; Gennaro Musi; Giovannalberto Pini; Riccardo Schiavina; Silvia Secco; Sergio Serni; Claudio Simeone; Giovanni Tasso; Daniele D'Agostino
Journal:  BMC Cancer       Date:  2021-01-11       Impact factor: 4.430

6.  Robotic-assisted, laparoscopic, and open radical cystectomy: surgical data of 1400 patients from The Italian Radical Cystectomy Registry on intraoperative outcomes.

Authors:  Angelo Porreca; Luca Di Gianfrancesco; Walter Artibani; Gian Maria Busetto; Giuseppe Carrieri; Alessandro Antonelli; Lorenzo Bianchi; Eugenio Brunocilla; Aldo Massimo Bocciardi; Marco Carini; Antonio Celia; Giovanni Cochetti; Andrea Gallina; Ettore Mearini; Andrea Minervini; Riccardo Schiavina; Sergio Serni; Daniele D'Agostino; Erica Debbi; Paolo Corsi; Alessandro Crestani
Journal:  Cent European J Urol       Date:  2022-05-04

7.  Benchmarking PASADENA Consensus along the Learning Curve of Robotic Radical Cystectomy with Intracorporeal Neobladder: CUSUM Based Assessment.

Authors:  Riccardo Lombardo; Riccardo Mastroianni; Gabriele Tuderti; Mariaconsiglia Ferriero; Aldo Brassetti; Umberto Anceschi; Salvatore Guaglianone; Cosimo De Nunzio; Antonio Cicione; Andrea Tubaro; Michele Gallucci; Giuseppe Simone
Journal:  J Clin Med       Date:  2021-12-19       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.